GH Research (NASDAQ: GHRS)
$12.76
(-0.5%)
-$0.07
Price as of June 13, 2025, 4:00 p.m. ET
GH Research Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
GH Research Company Info
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.